Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Computational and experimental in-vitro evaluation of effective orifice area of transcatheter aortic valves

EF 2011-12

Résumé
Cardiovascular diseases, affecting millions of people, is the number one cause of death in Canada and worldwide. According to the Heart and Stroke Foundation, every 7 minutes in Canada, someone dies from heart disease or stroke. While the spectrum of cardiac disease encompasses a broad range of disorders, the most common are valvular diseases that affect the Mitral and the Aortic valves which are responsible for 34% and 44% morbidity. Transcatheter aortic valve implantation (TAVI) currently under investigational use is fast becoming the norm for replacement of diseased aortic valves. For TAVI, the valves are delivered via a catheter and are either balloon expanded when the valve stent frame is made of stainless steel or self-expandable. For TAVI the final dimensions of the valve are no longer circular and the validity of the Gorlin equation for the computation of effective orifice area (EOA) is yet to be established. ViVitro's pulse duplicator is the most widely used heart simulator in the world. The usage of this heart simulator has been demonstrated for conducting both research and engineering testing of mechanical, prosthetic heart valves and currently TAVI. A first-time collaboration will be established between Dr. Dana Grecov from the University of British Columbia and ViVitro Labs Inc to study the validity of EOA calculations and propose a new, robust formula, accounting for viscous stresses and unsteadiness of the flow, that is applicable for TAVI. The proposed project focuses on experimental and computational in-vitro evaluation of hemodynamic performance of TAVI. The results will have direct implications on the viability of using a ViVitro Lab pulse duplicator for establishing safety and efficacy of heart valves for regulatory approval.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
417913-2011
Name nom
Grecov, Dana
Department département
Mechanical Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2200
Research subject group en
Fluid mechanics
Research subject group fr
Mécanique des fluides
Research subject en
Fluid mechanics
Research subject fr
Mécanique des fluides
Partie
1
Nb partie
1
Application title
Computational and experimental in-vitro evaluation of effective orifice area of transcatheter aortic valves
Keyword
NSERC
Application summary
Cardiovascular diseases, affecting millions of people, is the number one cause of death in Canada and worldwide. According to the Heart and Stroke Foundation, every 7 minutes in Canada, someone dies from heart disease or stroke. While the spectrum of cardiac disease encompasses a broad range of disorders, the most common are valvular diseases that affect the Mitral and the Aortic valves which are responsible for 34% and 44% morbidity. Transcatheter aortic valve implantation (TAVI) currently under investigational use is fast becoming the norm for replacement of diseased aortic valves. For TAVI, the valves are delivered via a catheter and are either balloon expanded when the valve stent frame is made of stainless steel or self-expandable. For TAVI the final dimensions of the valve are no longer circular and the validity of the Gorlin equation for the computation of effective orifice area (EOA) is yet to be established. ViVitro's pulse duplicator is the most widely used heart simulator in the world. The usage of this heart simulator has been demonstrated for conducting both research and engineering testing of mechanical, prosthetic heart valves and currently TAVI. A first-time collaboration will be established between Dr. Dana Grecov from the University of British Columbia and ViVitro Labs Inc to study the validity of EOA calculations and propose a new, robust formula, accounting for viscous stresses and unsteadiness of the flow, that is applicable for TAVI. The proposed project focuses on experimental and computational in-vitro evaluation of hemodynamic performance of TAVI. The results will have direct implications on the viability of using a ViVitro Lab pulse duplicator for establishing safety and efficacy of heart valves for regulatory approval.